Comparative Study Of Eortc Scoring System In Predicting The Prognosis In Nmibc

Objective To assess the clinical prognostic value of European organization of research and treatment of cancer scoring system (EORTC) for non-muscle-invasive bladder cancer (NMIBC) after transurethral resection (TUR-Bt) or TUR-Bt combined with pirarubicin intravesical irrigation pre-operation.Methods:Retrospective analysis of107patients treated with transurethral resection of bladder tumor in our hospital from January2008to January2013,among that85were TUR-Bt cases and22were TUR-Bt combined with pirarubicin intravesical irrigation pre-operation. Comparison of EORTC for NMIBC in recurrence and progression prediction after the two different surgical procedures.Results:Among the107patients,31cases had a recurrence in1year(24of TUR-Bt group and7of the other group), and5cases had a progression in1year(3of TUR-Bt group and2of the other group), the difference of was insignificant. The actual recurrence rate and progression rate of NMIBC in1year were matched with that predicting risk of EORTC (P>0.05). There was no significant difference of recurrence and progression predicting risk of EORTC before or after pirarubicin intravesical irrigation (P>0.05). Conclusions:The EORTC scoring system can predict prognosis of NMIBC accurately in the year after having surgery. Nevertheless,the value on predicting prognosis in5years after operation need more research to confirm. The EORTC scoring system had the same potential in predicting prognosis both in traditional TUR-Bt and that combined with pirarubicin intravesical irrigation pre-operation,which expanded the field of EORTC scoring system application.